| abstract |
NEW COMPOUNDS IN ACCORDANCE WITH FORMULA I, AND ITS PHARMACEUTICALLY ACCEPTABLE, SOLVATOS OR HYDRATION SALTS, IN WHICH EACH APPEARANCE OF IS SELECTED INDEPENDENTLY BETWEEN CH ON, X IS SELECTED BETWEEN THE GROUP THAT CONSISTS OF -CH2- -O -, RENT (C1-C6) - AMINO, RENT (C1-C6) -AMINO-CARBONIL-AMINO, RENT (C1-C6) -SULFONIL-AMINO, PHENYL-SULFONIL-AMINO, CARBONYL, -NH-C (O) -, N-RENT (C1-C6) -C (O), S (O) AND IN WHAT AND IS 0.1 OR 2; YN EN - (CH2) N-ES 1,2 O 3; AND R1, R2 AND R3 ARE AS DESCRIBED IN THIS DESCRIPTIVE MEMORY; PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THESE COMPOUNDS, AND METHODS FOR THE TREATMENT OF A SELF-IMMUNE DISEASE, AN INFLAMMATION, AN ALLERGY, A TRANSPLANTATION REJECTION, AND OTHER CIRCUMSTANCES IN WHICH THE ADMINISTRATION OF AN IMMUNITIVE SUPPLIES PRESENT. |